Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cedric Hermans

Showing results (131-140 of 222) with videos related to

Pageof 23
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 21, 2024
Reliability and construct validity of the ACTIVLIM-Hemo and Haemophilia Activities List (HAL) questionnaires in individuals with haemophiliaSébastien Lobet, Cedric Hermans, Valérie-Anne Chantrain, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 20, 2020
Management of COVID-19-associated coagulopathy in persons with haemophiliaSteven W Pipe, Radoslaw Kaczmarek, Alok Srivastava, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 13, 2019
Haemophilia in Côte d'Ivoire (the Ivory Coast) in 2017: Extensive data collection as part of the World Federation of Hemophilia's twinning programmeCatherine Lambert, N'Dogomo Meité, Ibrahima Sanogo, et al.
Transfusion Medicine (Oxford, England)|March 21, 2023
The use of prothrombin complex concentrate in chronic liver disease: A review of the literatureMarie-Astrid van Dievoet, Xavier Stephenne, Madeleine Rousseaux, et al.
Thrombosis and Haemostasis|January 18, 2006
Angiographic documentation of the efficacy of recombinant activated factor VII (NovoSeven) to control diffuse bleeding in major traumaBart Van Der Schueren, Frank Hammer, Franck Verschuren, et al.
Pharmaceutics|October 18, 2017
Modeling of Body Weight Metrics for Effective and Cost-Efficient Conventional Factor VIII Dosing in Hemophilia A ProphylaxisAlanna McEneny-King, Pierre Chelle, Severine Henrard, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 30, 2021
Adoption of emicizumab (Hemlibra®) for hemophilia A in Europe: Data from the 2020 European Association for Haemophilia and Allied Disorders surveyEvelien Krumb, Karin Fijnvandraat, Michael Makris, et al.
Journal of Thrombosis and Haemostasis : JTH|April 30, 2025
"Deconstructing the ISTH Hemophilia Guidelines for the clinician": comment from Mancuso et alMaria Elisa Mancuso, Pratima Chowdary, Leonard A Valentino, et al.
Orphanet Journal of Rare Diseases|February 3, 2019
Hemophilia carrier's awareness, diagnosis, and management in emerging countries: a cross-sectional study in Côte d'Ivoire (Ivory Coast)Catherine Lambert, N' Dogomo Meité, Ibrahima Sanogo, et al.
Orphanet Journal of Rare Diseases|March 25, 2014
The health and economic burden of haemophilia in Belgium: a rare, expensive and challenging diseaseSéverine Henrard, Brecht Devleesschauwer, Philippe Beutels, et al.
Pageof 23

Showing results (131-140 of 222) with videos related to

Sort By:
Pageof 23
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 21, 2024
Reliability and construct validity of the ACTIVLIM-Hemo and Haemophilia Activities List (HAL) questionnaires in individuals with haemophiliaSébastien Lobet, Cedric Hermans, Valérie-Anne Chantrain, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 20, 2020
Management of COVID-19-associated coagulopathy in persons with haemophiliaSteven W Pipe, Radoslaw Kaczmarek, Alok Srivastava, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 13, 2019
Haemophilia in Côte d'Ivoire (the Ivory Coast) in 2017: Extensive data collection as part of the World Federation of Hemophilia's twinning programmeCatherine Lambert, N'Dogomo Meité, Ibrahima Sanogo, et al.
Transfusion Medicine (Oxford, England)|March 21, 2023
The use of prothrombin complex concentrate in chronic liver disease: A review of the literatureMarie-Astrid van Dievoet, Xavier Stephenne, Madeleine Rousseaux, et al.
Thrombosis and Haemostasis|January 18, 2006
Angiographic documentation of the efficacy of recombinant activated factor VII (NovoSeven) to control diffuse bleeding in major traumaBart Van Der Schueren, Frank Hammer, Franck Verschuren, et al.
Pharmaceutics|October 18, 2017
Modeling of Body Weight Metrics for Effective and Cost-Efficient Conventional Factor VIII Dosing in Hemophilia A ProphylaxisAlanna McEneny-King, Pierre Chelle, Severine Henrard, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 30, 2021
Adoption of emicizumab (Hemlibra®) for hemophilia A in Europe: Data from the 2020 European Association for Haemophilia and Allied Disorders surveyEvelien Krumb, Karin Fijnvandraat, Michael Makris, et al.
Journal of Thrombosis and Haemostasis : JTH|April 30, 2025
"Deconstructing the ISTH Hemophilia Guidelines for the clinician": comment from Mancuso et alMaria Elisa Mancuso, Pratima Chowdary, Leonard A Valentino, et al.
Orphanet Journal of Rare Diseases|February 3, 2019
Hemophilia carrier's awareness, diagnosis, and management in emerging countries: a cross-sectional study in Côte d'Ivoire (Ivory Coast)Catherine Lambert, N' Dogomo Meité, Ibrahima Sanogo, et al.
Orphanet Journal of Rare Diseases|March 25, 2014
The health and economic burden of haemophilia in Belgium: a rare, expensive and challenging diseaseSéverine Henrard, Brecht Devleesschauwer, Philippe Beutels, et al.
Pageof 23